Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0847097 (
acidity
)
15,165
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was carried out in order to compare the effects of mealtime and bedtime regimens of ranitidine on gastric
acidity
. Fifteen duodenal ulcer patients in clinical remission were randomized to receive in single-blind fashion either placebo, ranitidine 300 mg at night (2200 hr) or ranitidine 150 mg three times a day given before each of the three daily meals (1800, 0800 and 1200 hr). Over 24 hr, the two active treatments produced a significantly greater acid inhibition than placebo, while the single daily regimen was superior to the three times a day regimen of ranitidine in terms of both rise in pH values (P less than 0.001) and duration of action expressed as time spent above 3.0 pH units (P less than 0.05). The analysis of these two parameters during fractioned periods of the circadian cycle showed that the three divided doses of ranitidine were more effective during the daytime (P less than 0.01) and the evening (P less than 0.001), whereas the bedtime dose of ranitidine was superior during the night (P less than 0.0001). Thus a short-lasting antisecretory action, which is, however, capable of fully controlling the high
acidity
of postprandial periods, might be the key to understanding the results of several recent clinical trials in which the suppression of daytime gastric
acidity
has been shown to promote similar or even faster duodenal ulcer healing rates than the suppression of nocturnal
acidity
.
Dig Dis Sci 1992
Sep
PMID:Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine. 150 87
The effect of gastric
acidity
on the oral absorption of the quinolone antibiotic enoxacin was evaluated in 12 healthy volunteers. In a randomized, crossover design, single 400 mg oral enoxacin doses were administered on four occasions: alone, after 50 mg intravenous ranitidine, after 2 micrograms/kg subcutaneous pentagastrin, and after combined ranitidine and pentagastrin treatment. Gastric pH was monitored by radiotelemetry capsule for 4 hours after enoxacin administration. Ranitidine pretreatment reduced enoxacin oral bioavailability by an average of 26%. This effect was abolished when pentagastrin was used to maintain low gastric pH. Thus the ranitidine-induced decrease in enoxacin oral bioavailability probably results from a decrease in gastric
acidity
rather than from an interaction with ranitidine itself.
Clin Pharmacol Ther 1992
Sep
PMID:Effect of gastric acidity on enoxacin absorption. 152 81
The
acidity
induced by the action of bacteria in milk samples was monitored amperometrically by using a platinum microelectrode. The measurements were performed directly on commercial packs of milk, stored at 32 degrees C, and were continued for 9-10 d after inoculation. The data were compared with those obtained by measuring the pH of the samples and the results are discussed on the basis of the metabolism of each bacterial species. The effects of the following bacteria were examined: Staphylococcus aureus, Bacillus cereus, Streptococcus faecalis, Bacillus subtilis, Aeromonas, and Corynebacterium.
Analyst 1991
Sep
PMID:Amperometric monitoring of bacteria-induced milk acidity using a platinum disc microelectrode. 175 20
This review examines the literature on drug interactions with omeprazole. Different mechanisms have been proposed as potential causes for such interactions. First, the absorption of some drugs might be altered due to the decreased intragastric
acidity
resulting from omeprazole treatment. There was no effect of omeprazole on the absorption of amoxycillin, bacampicillin and alcohol, while the amount of digoxin and nifedipine absorbed was increased by 10 and 21%, respectively, both increases probably being of no clinical significance. Secondly, the metabolism of high clearance drugs might be altered by changes in liver blood flow, although that is not affected by omeprazole, as indicated by the unchanged elimination of indocyanine green. In addition, the clearance of intravenously administered lidocaine (lignocaine) [a high clearance drug] was unaffected by omeprazole, further indicating that the latter does not alter liver blood flow. Thirdly, since omeprazole is a substituted benzimidazole, it might have the potential to interfere with the metabolism of other drugs by altering the activity of drug metabolising enzymes in the cytochrome P450 system, through either induction or inhibition. There is no indication of induction of this enzyme system in any interaction study with omeprazole. As regards inhibition, on the other hand, there is now considerable information available which indicates that omeprazole has the potential to partly inhibit the metabolism of drugs metabolised to a great extent by the cytochrome P450 enzyme subfamily IIC (diazepam, phenytoin), but not of those metabolised by subfamilies IA (caffeine, theophylline), IID (metoprolol, propranolol) and IIIA (cyclosporin, lidocaine, quinidine). Since relatively few drugs are metabolised mainly by IIC compared with IID and IIIA, the potential for omeprazole to interfere with the metabolism of other drugs appears to be limited.
Clin Pharmacokinet 1991
Sep
PMID:Omeprazole drug interaction studies. 176 70
Whole milk was pasteurized and concentrated two times by ultrafiltration. Starter cultures, Lactococcus lactis ssp. cremoris and Lactococcus lactis ssp. lactis, were propagated in either reconstituted skim milk, two times UF retentate, or UF permeate, or a direct vat system was used for the starter culture. The cheese milk was simultaneously inoculated with starter culture and Pseudomonas fragi 4973, Staphylococcus aureus 196E, and Salmonella typhimurium var. Hillfarm. Control whole milk, UF control milk, inoculated whole milk, and inoculated UF milk were made into Monterey Jack cheese using traditional procedures. The process of cheese manufacture was followed by determination of pH, titratable
acidity
, and microbial population levels. The cheeses were stored for 6 mo and analyzed every month for percentage solids and microbial population levels. Generally, numbers of contaminant microbes increased at a similar rate during manufacture in all cheeses. During the 6-mo ripening period, bacterial starter culture population levels remained high, psychrotrophs declined slowly, Staphylococcus levels remained stable, and Salmonella populations decreased. No Staphylococcus enterotoxin was detected by reverse passive latex agglutination assay.
J Dairy Sci 1991
Sep
PMID:The behavior of selected microorganisms during the manufacture of high moisture Jack cheeses from ultrafiltered milk. 177 45
The antisecretory effects of H2-receptor antagonists are limited by food ingestion. The contributions of the cephalic-vagal and gastrinergic mechanisms to this interaction were examined in two 14-hour randomized, cross-over studies in 24 healthy volunteers. In the first study, either ranitidine or placebo was administered IV by a pH-feedback-controlled infusion pump during fasting, modified sham feeding, or food ingestion. Sham feeding resulted in a well-defined and abrupt interaction with the antisecretory effect of ranitidine (lasting 2-3 hours), after which fasting pH levels were regained. The second study, with the same design, showed that gastrin release occurred during this cephalic-vagal phase but was not attenuated by the additional infusion of the anticholinergic pirenzepine. Following eating, intragastric
acidity
increased and remained elevated for more than 6 hours. This increase was accompanied by prolonged hypergastrinemia, which was not diminished by pirenzepine. Pirenzepine did, however, enhance the antisecretory effect of ranitidine after both sham feeding and food ingestion. The interaction of food or sham feeding with the antisecretory effect of H2 antagonists is a consistent phenomenon. In both the cephalic-vagal and the gastric phases of secretion, this interaction appears to be partially mediated by a noncholinergic release of gastrin.
Gastroenterology 1991
Sep
PMID:The cephalic and gastric phases of gastric secretion during H2-antagonist treatment. 186 Jun 25
Infections due to Salmonella serotype enteritidis have increased markedly in the northeastern United States. Due to the potential severity of these infections, host risk factors for infection were determined in the largest nosocomial S. enteritidis outbreak to have occurred in the United States. In a case-control study, patients in a New York City hospital who developed infection after exposure to an S. enteritidis-contaminated meal were more likely to be medication-dependent diabetics than were those who did not develop infection (17/75 vs. 7/80, Mantel-Haenszel adjusted odds ratio = 3.1, 95% confidence interval = 1.1, 8.6). Proposed mechanisms for diabetes as a risk factor for infection include decreased gastric
acidity
in diabetic patients and an autonomic neuropathy of the small bowel that reduces intestinal motility and prolongs gastrointestinal transit time.
J Infect Dis 1991
Sep
PMID:Diabetes mellitus--a newly described risk factor for infection from Salmonella enteritidis. 186 41
This study evaluated changes in respiratory health associated with daily changes in fine particulate pollution (PM10). Participants included a relatively healthy school-based sample of fourth and fifth grade elementary students, and a sample of patients with asthma 8 to 72 yr of age. Elevated PM10 pollution levels of 150 micrograms/m3 were associated with an approximately 3 to 6% decline in lung function as measured by peak expiratory flow (PEF). Current day and daily lagged associations between PM10 levels and PEF were observed. Elevated levels of PM10 pollution also were associated with increases in reported symptoms of respiratory disease and use of asthma medication. Associations between compromised respiratory health and elevated PM10 pollution were observed even when PM10 levels were well below the 24-h national ambient air quality standard of 150 micrograms/m3. Associations between elevated PM10 levels, reductions in PEF, and increases in symptoms of respiratory disease and asthma medication use remained statistically significant even when the only pollution episode that exceeded the standard was excluded. Concurrent measurements indicated that little or no strong particle
acidity
was present.
Am Rev Respir Dis 1991
Sep
PMID:Respiratory health and PM10 pollution. A daily time series analysis. 189 9
As part of our continuing studies on heparin, the present paper uses 13C-n.m.r. spectroscopy to examine the
acidity
of heparin's uronic acid carboxylate groups. Heparin contains three different uronic acids. In porcine mucosal heparin these account for approx. 91, 7 and 2 mol% of the total uronic acid residues. These are alpha-L-idopyranosyluronic acid 2-sulphate, beta-D-glucopyranosyluronic acid and alpha-L-idopyranosyluronic acid. The pKa values of their carboxylate groups were determined as 3.13 (using heparin), 2.79 (using heparin) and 3.0 (predicted by using model compounds) respectively. 18C-n.m.r. spectroscopy, performed at various pH values, provided a convenient method of simultaneously determining the pKa of multiple carboxylate groups, of similar
acidity
, within heparin D-Glucopyranosyluronic acid and heparin-derived di-, tetra- and hexa-saccharides were used as model compounds to determine pKa values of the different carboxy groups. The results suggested that molecular size had an effect on pKa. Unambiguous assignment of carboxy carbon resonances were accomplished through the use of two-dimensional n.m.r. spectroscopy. Finally, application of this method to the simplest model compound, D-glucopyranosyluronic acid, permitted the determination of the pKa of both its alpha- and beta-anomers.
Biochem J 1991
Sep
15
PMID:Determination of the pKa of glucuronic acid and the carboxy groups of heparin by 13C-nuclear-magnetic-resonance spectroscopy. 189 57
Proximal duodenum was perfused with various solutions and mucosal permeability assessed by measuring the clearance of 51Cr labelled ethylenediaminetetra-acetate (EDTA) from blood-to-intestinal lumen in anaesthetized rats. Net flux of fluid was determined by measurement of effluent weight changes. Perfusion of duodenum with 50 mM NaCl significantly increased fluid absorption but had no effect on EDTA clearance. EDTA clearance was unaffected by perfusion with 400 mM or 800 mM mannitol. Perfusion with 400 mM NaCl induced a sustained fluid secretion and a small but irregular increase (40%) in EDTA clearance. A significant 3.6-fold increase in clearance was obtained in response to perfusion of duodenum with deionized water. Similarly, perfusion with either 20 mM HCl or 50 mM ethyleneglycol-bis-(beta-amino-ethylether)-N,N'-tetraacetic acid (EGTA) significantly increased the EDTA clearance 3.3-fold and 2-fold respectively. Perfusion with a hypotonic HCl-solution (10 mM HCl + 40 mM NaCl) increased fluid absorption and the EDTA clearance. It is concluded that no positive linear relationship exists between luminal osmolality and 51Cr-EDTA movement across the mucosa. It is postulated that high luminal
acidity
or extreme hypotonicity increase the EDTA clearance by widening of and/or disruption of intercellular junctional structure.
Acta Physiol Scand 1991
Sep
PMID:Characterization of 51Cr-EDTA as a marker of duodenal mucosal permeability. 195 98
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>